logo
Plus   Neg
Share
Email

Elanco To Acquire Animal Health Division Of Bayer In $7.6 Bln Deal - Quick Facts

Elanco (ELAN), a global animal health company, has agreed to acquire the animal health division of Bayer AG (BAYN). The total deal is valued at $7.6 billion with a 70 percent to 30 percent cash-to-equity mix. Bayer AG will receive $5.32 billion in cash, and $2.28 billion or approximately 68 million Elanco Animal Health shares. The deal is anticipated to close in mid-2020.

Elanco expects the acquisition to provide adjusted EPS accretion in the first full year post-closing, and then high single to low double-digit percentage accretion in year two.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The National Retail Federation Chief Economist Jack Kleinhenz said it was too early to say how quickly or smoothly the U.S. economy would stage a recovery following the "sizable disruptions" due to the coronavirus pandemic. However, he noted that the reopening of businesses and the resumption of economic activity is a significant step forward. Following the recall of type 2 diabetes medication Metformin Hydrochloride Extended-Release (ER) by Apotex last week, the U.S. Food and Drug Administration or FDA has recommended more pharmaceutical companies, who are manufacturers of the drug formulation, to recall their products. Hundreds of Facebook employees staged a "virtual walkout" on Monday to protest the company's decision not to act on recent controversial posts by President Donald Trump on the social media platform. The employees criticized Facebook chief executive Mark Zuckerberg's decision to not moderate a post from Trump last Thursday.
RELATED NEWS
Follow RTT